Anthera Pharmaceuticals

(OTC) ANTH

Current Price$0.00

Market CapN/A

Since IPO (2010)-100%

5 Year-100%

1 Year-99%

1 Month-99%

Anthera Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$9.86M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-2.74 (Low)

Dividend

$0.00

Beta (Volatility)

-2.74 (Low)

Price

$0.00

Volume

36,191

Open

$0.00

Price

$0.00

Volume

36,191

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-2.74 (Low)

Price

$0.00

Volume

36,191

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

ANTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anthera Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Headquarters

Houston, TX 77002, US

ANTH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

35%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

26.18M

Volume

36.19K

Avg. Volume

2.03K

Financials (TTM)

Gross Profit

$281.00K

Operating Income

$36.43M

EBITDA

$26.59M

Operating Cash Flow

$36.90M

Capital Expenditure

$0.00

Free Cash Flow

$36.90M

Cash & ST Invst.

$2.20M

Total Debt

$0.00

Anthera Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2018YOY CHG

Revenue

$0.00

N/A

Gross Profit

$7.47K

+3.0%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$4.43M

+62.1%

EBITDA

$10.81M

-2.4%

Quarterly Fundamentals

Name

Q1 2018YOY CHG

Net Cash

$8.09M

-60.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.61%

N/A

Return on Invested Capital

35.10%

N/A

Free Cash Flow

$9.38M

+34.5%

Operating Cash Flow

$9.38M

+34.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PZRXQPhaseRx, Inc.

PZRXQPhaseRx, Inc.$0.00+0.00%

NTIINeurobiological Technologies, Inc.

NTIINeurobiological Technologies, Inc.$0.00+0.00%

SYVCSynovics Pharmaceuticals, Inc.

SYVCSynovics Pharmaceuticals, Inc.$0.00+0.00%

COTQFCotinga Pharmaceuticals Inc.

COTQFCotinga Pharmaceuticals Inc.$0.00+0.00%

SNNAQSienna Biopharmaceuticals, Inc.

SNNAQSienna Biopharmaceuticals, Inc.$0.00+0.00%

CMRAComera Life Sciences Holdings, Inc.

CMRAComera Life Sciences Holdings, Inc.$0.00+0.00%

SVSOSheerVision, Inc.

SVSOSheerVision, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

Questions About ANTH

What is the current price of Anthera Pharmaceuticals?

Anthera Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Anthera Pharmaceuticals?

Over the past 52 weeks, Anthera Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Anthera Pharmaceuticals have?

Anthera Pharmaceuticals total debt is unavailable.

How much cash does Anthera Pharmaceuticals have on hand?

Anthera Pharmaceuticals does not have cash on hand data available.

What is Anthera Pharmaceuticals’s dividend yield?

Anthera Pharmaceuticals does not currently have a dividend yield.

Anthera Pharmaceuticals

Anthera Pharmaceuticals Financials at a Glance

ANTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Anthera Pharmaceuticals

ANTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Anthera Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANTH

What is the current price of Anthera Pharmaceuticals?

What is the 52-week range for Anthera Pharmaceuticals?

How much debt does Anthera Pharmaceuticals have?

How much cash does Anthera Pharmaceuticals have on hand?

What is Anthera Pharmaceuticals’s dividend yield?

Premium Investing Services